Join
Live feed
·
INSIDERFilingvia Quantisnow
Mereo BioPharma Group plc logo

Chief Scientific Officer Lewicki John A. converted options into 46,000 units of American Depositary Shares representing Ordinary Shares, increasing direct ownership by 94% to 94,779 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
MREO· Mereo BioPharma Group plc
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MREO (Mereo BioPharma Group plc) and more on Quantisnow.